Does director interlock impact corporate R&D investment?

被引:30
|
作者
Han, Jie [1 ]
Bose, Indranil [2 ]
Hu, Nan [3 ]
Qi, Baolei [1 ]
Tian, Gaoliang [4 ]
机构
[1] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China
[2] Indian Inst Management Calcutta, Management Informat Syst, Kolkata 700104, India
[3] Stevens Inst Technol, Accounting, Hoboken, NJ USA
[4] Xi An Jiao Tong Univ, Sch Management, Dept Accounting & Finance, Xian, Peoples R China
关键词
Director interlock; Information transmission; Inter-organizational imitation theory; R&D; TOP MANAGEMENT TEAM; FIRM PERFORMANCE; INTERORGANIZATIONAL IMITATION; BOARD INTERLOCKS; HIGH-TECHNOLOGY; INNOVATION; UNCERTAINTY; STRATEGY; ADOPTION;
D O I
10.1016/j.dss.2015.01.001
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
This paper investigates the effect of director interlock on corporate research & development (R&D) investment from the perspective of inter-organizational imitation. We argue that managers will imitate the R&D investment intensity of their interlocked-firms when deciding how much to spend in R&D for their own firm. Following prior literature, we further argue that under different types of interlocking director and industry characteristics, the impact of director interlock on corporate R&D spending is different. Using a sample of public firms listed in Chinese Shanghai and Shenzhen Stock Exchanges, our empirical results show that managers imitate the prior R&D investment intensity of their interlock partners, and the impact of director interlock on corporate R&D intensity is stronger when the interlocking director is an inside director in the focal firm or when the focal firm and interlock firm belong to the same industry. Our results still hold when we account for the potential sample selection bias, firm similarity, and the confounding factors that can contribute through unobserved industry characteristics. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 50 条
  • [31] The Dynamic Impact of Exporting on Firm R&D Investment
    Maican, Florin G.
    Orth, Matilda
    Roberts, Mark J.
    Vuong, Van Anh
    [J]. JOURNAL OF THE EUROPEAN ECONOMIC ASSOCIATION, 2023, 21 (04) : 1318 - 1362
  • [32] The impact of price controls on pharmaceutical R&D investment
    Abbott, TA
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 380 - 380
  • [33] Dual function of corporate social responsibility on R&D strategy: Moderating effect of board interlock
    Tian, Ming
    Wang, Teng
    Li, Xiaotong
    [J]. MANAGERIAL AND DECISION ECONOMICS, 2021, 42 (06) : 1492 - 1508
  • [34] Is there a moderate range of impact of financialization on corporate R&D?
    Li, Zhenghui
    Wang, Yan
    [J]. PLOS ONE, 2021, 16 (06):
  • [35] IMPACT OF CORPORATE R&D ON EFFICIENCY IN OECD INDUSTRIES
    Dos-Santos, Maria Jose Palma Lampreia
    Diz, Henrique
    [J]. INNOVATION, ENTREPRENEURSHIP AND DIGITAL ECOSYSTEMS, 2016, : 645 - 658
  • [36] International operations and corporate R&D investment: Evidence from China
    Fu, Ying
    Li, Jiaying
    Wu, Ying
    [J]. PLOS ONE, 2024, 19 (09):
  • [37] Supply Chain Relational Capital and Corporate NPD R&D Investment
    Xu, Weili
    Lin, Meishun
    [J]. FINANCE RESEARCH LETTERS, 2024, 61
  • [38] Empirical Research on the Relationship between R&D Investment and Corporate Performance
    Zhu, Jianjun
    Liu, Yunpeng
    [J]. 2016 EBMEI INTERNATIONAL CONFERENCE ON HUMANITY AND SOCIAL SCIENCE (EBMEI-HSS 2016), 2016, 63 : 79 - 84
  • [39] Firm-level political risk and corporate R&D investment
    Boah, Emmanuel
    Ujah, Nacasius U.
    [J]. JOURNAL OF EMPIRICAL FINANCE, 2024, 78
  • [40] Corporate governance structure, managerial discretion, and the R&D investment in China
    Dong, Jing
    Gou, Yan-nan
    [J]. INTERNATIONAL REVIEW OF ECONOMICS & FINANCE, 2010, 19 (02) : 180 - 188